Home
    Timetable
    Registration
    Accommodation
    Contact
Home
Welcome Note
Committees
Timetable
Preliminary Topics
List of Faculty
Scientific Program
Anterior Segment Section
Retina Section
Glaucoma Section
Neuro-Ophthalmology
Pediatrics
Surgical Marathon
Symposia
Poster Presentations
Group A
Group B
Poster Presentation Guidelines
Sponsorship & Exhibition
Sponsors
Registration
Invitation Letter
Accommodation
Swissôtel The Bosphorus
CME
General Information
Before you travel...
Italian Agent
Chinese Agent
Transportation
About Istanbul
Partners
Previous Congresses
COPHy 2010
COPHy 2011
The 3rd World Congress on
Controversies in Ophthalmology (COPHy)
Anterior Segment, Retina, Glaucoma

Istanbul, Turkey, March 22 - 25, 2012
  Glaucoma Section Print
 
Friday, March 23, 2012
 
Glaucoma I
Controversies in Medical Treatment of Glaucoma
Room: Genéve-Luzem
08:30-10:00
Chairpersons: A. Heijl, Sweden & K. Martin, UK
    
08:30-09:00
08:30-08:40
 
08:40-08:50
  
08:50-09:00
 
09:00-09:30
09:00-09:10
  
09:10-09:20
  
09:20-09:30
Debate I: Initial monotherapy is an obsolete dogma
Yes
A. Heijl, Sweden
No
S. Gandolfi, Italy
Discussion
  
Debate II: Are any currently available drugs neuroprotective?
Yes
S. Gandolfi, Italy
No
K. Martin, UK
Discussion
 
09:30-10:00
Debate III: Exfoliation and ocular hypertension is such a dangerous combination that all patients should be treated
09:30-09:40
 
09:40-09:50
  
09:50-10:00
Yes
A. Heijl, Sweden
No 
S. Vernon, UK (abstract from E. Hoffman,Germany)
Discussion
     
Glaucoma II
Controversies in Glaucoma Diagnosis and Progression
Room: Genéve-Luzem
10:30-12:00
Chairpersons: A. Heijl, Sweden & K. Martin, UK      
   
10:30-11:00
10:30-10:40
    
10:40-10:50
  
10:50-11:00
 
11:00-11:30
Debate I: Molecular biomarkers will be useful
Yes
F. Grus, Germany
No
K. Martin, UK      
Discussion
  
Debate II: It is time to stop confusing ophthalmologists with talk of so-called "selective perimetry"
11:00-11:10
  
11:10-11:20
  
11:20-11:30
 
11:30-12:00
11:30-11:40
   
11:40-11:50
  
11:50-12:00
Yes
A. Heijl, Sweden
No
A. Viswanathan, UK
Discussion
   
Debate III: How best to assess progression in the future?
Smarter use of existing methodologies
A. Viswanathan, UK
Imaging sick and dying cells
K. Martin, UK
Discussion
    
Glaucoma III
Controversies in Laser Treatment in Glaucoma
Room: Genéve-Luzem
14:00-15:30
Chairperson: A. Heijl, Sweden
    
14:00-14:30
14:00-14:10
  
14:10-14:20
  
14:20-14:30
 
14:30-15:00
14:30-14:40
  
14:40-14:50
   
14:50-15:00
 
15:00-15:30
15:00-15:10
 
15:10-15:20
    
15:20-15:30
  
Debate I: SLT should be first-line?
Yes
S. Gandolfi, Italy
No
G. Gazzard, UK
Discussion
 
Debate II: Should endodiode be used more?
Yes
P. Bloom, UK
No
S. Vernon, UK
Discussion
 
Debate III: Should iridoplasty be used more?
Yes
A. White, UK
No
G. Gazzard, UK
Discussion
 
 
Saturday, March 24, 2012
  
Glaucoma IV
Controversies in Surgical Management of Glaucoma
Room: Fuji 2
08:30-10:00
Chairperson: A. Heijl, Sweden
    
08:30-09:00
08:30-08:40
   
08:40-08:50
  
08:50-09:00
  
    
09:00-10:00
09:00-09:15
   
09:15-09:30
  
09:30-09:45
 
09:45-10:00
  
Debate I: What is the best treatment for neovascular glaucoma?
Tubes
J. Brookes, UK
Cycloablation
S. Vernon, UK
Discussion
     
Debate II: What is the most promising new surgical technique?
iStent
P. Bloom, UK
Trabectome
A. White, UK
Canaloplasty
M. Tetz, Germany
Better use of conventional tubes
J. Brookes, UK
                

Home   
Copyright © 2008 Comtecmed.com. All rights reserved.   The website was last updated on 12/03/2012 Created by    WebStudio.co.il